Resultados de la búsqueda

Salinas P, Romaguera R, Gómez-Lara J, Brugaletta S, Gómez-Menchero A, Martín P, Romero M, García-Blas S, Jiménez M, Jiménez VA, Bordes P, Bayón J, Salvatella N, Alameda M, Hyun-Lee D, Trillo-Nouche R, López-Benito M, Frutos A, Moreu J, García Del Blanco B, Mohandes M, Bosa Ojeda F, Hernández Hernández F, Pinar-Bermúdez E, Jiménez-Quevedo P, Rosselló X, Pocock S, Sabaté M, Gómez-Hospital JA, Comin-Colet J, Gonzalo N, Fernández Ortiz A; SUGAR trial Investigators. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial. Heart (2025) Jun 25 [Epub ahead of print]

Rossello X, Gonzalez-Del-Hoyo M, Aktaa S, Gale CP, Barbash I, Claeys MJ, Coughlan JJ, Ferreira JP, Galbraith M, Leosdottir M, Schiele F, Raposeiras-Roubin S, Gimenez MR, Byrne RA, Ibanez B. European Society of Cardiology quality indicators for the management of acute coronary syndromes: developed in collaboration with the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the ESC. Eur Heart J Acute Cardiovasc Care (2025) 14:145-154

Borowiec BG, Joyce W, Glover CN. Editorial: Methods in Comparative Biochemistry and Physiology - Challenges and Opportunities. COMP BIOCHEM PHYS B (2025) 278:111094

Llorens P, Haro A, Gil V, Alquézar-Arbé A, Jacob J, Espinosa B, González de la Torre MÁ, Núñez J, Rossello X, Miró Ò; en representación del grupo de investigación ICA-SEMES. Factors associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors after an episode of acute heart failure and prognostic impact. Rev Clin Esp (2025) 225:502300

Zhao D, Rubini M. Improving English proficiency for scientific communication by non-fluent speakers. Nat Rev Cardiol (2025) 22:141-142

Medina-Hernández D, Cádiz L, Mastrangelo A, Moreno-Arciniegas A, Fernández Tocino M, Cueto Becerra AA, Díaz-Guerra Priego A, Skoza WA, Higuero-Verdejo MI, López-Martín GJ, Pérez-Martínez C, de Molina-Iracheta A, Caballero-Valderrama M, Sánchez-González J, Sancho D, Fuster V, Galán-Arriola C, Ibáñez B. SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial Energetics. JACC CardioOncol (2025) 7:171-184
Link to the full text in Repisalud

Byrne R, Coughlan JJ, Rossello X, Ibanez B; Members of the Task Force for the 2023 ESC Guidelines for the management of acute coronary syndromes. Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings. Eur Heart J Qual Care Clin Outcomes (2025) Mar 28 [Epub ahead of print]

Real C, Ferrera C, Vázquez-Álvarez ME, Huanca M, Noriega FJ, Gutiérrez-Ibañes E, Mañas-Hernández AM, Ramos-López N, Juárez M, Jiménez-Quevedo P, Elízaga J, Viana-Tejedor A, Salinas P. Terapias de reperfusión en pacientes con embolia de pulmón de riesgo intermedio-alto y de riesgo alto: datos de un registro multicéntrico [Reperfusion therapies in patients with intermediate- and high-risk pulmonary embolism: insights from a multicenter registry]. REC Interv Cardiol (2025) 6:172-181

Joyce W, He K, Zhang M, Ogunsola S, Wu X, Joseph KT, Bogomolny D, Yu W, Springer MS, Xie J, Signore AV, Campbell KL. Genetic excision of the regulatory cardiac troponin I extension in high-heart rate mammal clades. Science (2024) 385:1466-1471

Byrne R, Coughlan JJ, Rossello X, Ibanez B. The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J (2024) 45:1193-1195
Link to the full text in Repisalud